학술논문

23P Immunosenescence (iSenescence) correlates with progression (PD) to PD-(L)1 inhibitors (IO) and not to platinum-chemotherapy (PCT) in advanced non-small cell lung cancer (aNSCLC) patients (pts).
Document Type
Article
Source
Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Subject
*PEMETREXED
*NON-small-cell lung carcinoma
*IMMUNOSENESCENCE
*MOLECULAR oncology
Language
ISSN
0923-7534